The resources below support pathology workforce, pathology practices and accrediting agencies by providing guidance on the NPAAC accreditation materials including the standards
Found 319 result(s)
The National Pathology Accreditation Scheme (NPAS) accredits Australian pathology laboratories.
The National Pathology Accreditation Advisory Council (NPAAC) accreditation materials include pathology standards that protect the Australian public from harm and ensure consistency of pathology services.
The Commission is reviewing the Diagnostic Imaging Accreditation Standards and Scheme to improve the safety and quality of patient care.
Accreditation provides assurances to the community that healthcare services meet the expected standards for safety and quality. It is a formal program where trained independent reviewers assess evidence of implementation for specified standards.
The Commission has developed a range of resources to support hospitals measure safety culture.
A range of media and communications assets are available to help promote the Fourth Australian Atlas of Healthcare Variation 2021.
Presentations from the Australasian Delirium Association Conference, DECLARED 2021, upon the launch of the updated Delirium Clinical Care Standard.
The Commission undertakes projects and programs to support the safe and quality use of medicines. This includes national guiding principles and national indicators for QUM in Australian hospitals.
From 1 January 2023, the Commission became the custodian of a range of QUM functions, expanding our role in QUM stewardship. For more information about these QUM functions please visit the QUM Transition page.
Summaries of the key data findings for each state and territory, as well as a national data summary from the fourth Atlas 2021 are available for download:
The Commission consulted widely in the development of this Atlas including with a number of clinical colleges and societies, the Australian Government Department of Health, state and territory health departments and healthcare organisations. The Commission also wishes to acknowledge the significant contribution of its advisory groups and other experts.
The Commission made the following overarching recommendations in light of the findings of the Fourth Australian Atlas of Healthcare Variation. These broad recommendations relate to more than one of the topics covered in the fourth Atlas.
The Fourth Australian Atlas of Healthcare Variation examines variation in healthcare use according to where people live. It covers six clinical areas: early planned births; chronic disease and infection; ear, nose and throat surgery in children and young people; lumbar spinal surgery; gastrointestinal investigations; and medicines use in older people. The Atlas was launched by the Hon Greg Hunt MP on 28 April 2021.
Missed a recent webinar? Want to review the content from a past session? Check out the Program Series Webinar archives for recordings of past events. Access to the archives is free and a great way to review session tips or check out webinars that you have missed.
This chapter provides a high level overview of the health system's response to the Australian Atlas of Healthcare Variation series (the Atlas series). It identifies the levers used to implement change and includes practical case studies.
The Escalation Mapping Template (EMT) will help to determine which processes for recognising and responding to deterioration in a person’s mental state are working effectively, and identify if there are any problems and/or gaps in current processes.
The Commission wishes to acknowledge the significant contribution of its steering committee members in the development of the Better Care Everywhere program series.
The Commission is concerned for older people and people with disability in all settings where psychotropic medicines are being prescribed inappropriately as a form of restrictive practice to control behaviour, off-label and for extended periods without review.
The Commission has undertaken a number of initiatives to reduce inappropriate use of psychotropic medicines.
Quality statement 6 - Cataract Clinical Care Standard
Options for a patient with bilateral cataract are discussed when the decision about first-eye surgery is being made. Second-eye surgery is offered using similar criteria as for the first eye, but the potential benefits and harms of a delay in second-eye surgery are also considered, leading to a shared decision about second-eye surgery and its timing.
Quality statement 5 - Cataract Clinical Care Standard
A patient is prioritised for cataract surgery according to clinical need. Prioritisation protocols take into account the severity of the patient’s visual impairment and vision-related activity limitations, the potential harms of delayed surgery, any relevant comorbidity and the expected benefits of surgery.